- Home
- KTB vs LNTH Comparison
KTB vs LNTH Comparison
Compare KTB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTB
- LNTH
- Stock Information
- Founded
- KTB 2018
- LNTH 1956
- Country
- KTB United States
- LNTH United States
- Employees
- KTB N/A
- LNTH N/A
- Industry
- KTB Apparel
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- KTB Consumer Discretionary
- LNTH Health Care
- Exchange
- KTB Nasdaq
- LNTH Nasdaq
- Market Cap
- KTB 3.6B
- LNTH 3.6B
- IPO Year
- KTB N/A
- LNTH 2015
- Fundamental
- Price
- KTB $80.71
- LNTH $52.78
- Analyst Decision
- KTB Strong Buy
- LNTH Strong Buy
- Analyst Count
- KTB 6
- LNTH 5
- Target Price
- KTB $91.33
- LNTH $91.60
- AVG Volume (30 Days)
- KTB 592.7K
- LNTH 1.6M
- Earning Date
- KTB 10-30-2025
- LNTH 11-05-2025
- Dividend Yield
- KTB 2.49%
- LNTH N/A
- EPS Growth
- KTB 5.71
- LNTH N/A
- EPS
- KTB 4.47
- LNTH 3.77
- Revenue
- KTB $2,650,638,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- KTB $20.34
- LNTH N/A
- Revenue Next Year
- KTB $11.09
- LNTH $3.24
- P/E Ratio
- KTB $18.66
- LNTH $14.58
- Revenue Growth
- KTB 3.44
- LNTH 5.75
- 52 Week Low
- KTB $50.00
- LNTH $47.25
- 52 Week High
- KTB $96.80
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- KTB 63.18
- LNTH 38.29
- Support Level
- KTB $77.10
- LNTH $51.94
- Resistance Level
- KTB $84.12
- LNTH $55.24
- Average True Range (ATR)
- KTB 2.19
- LNTH 1.96
- MACD
- KTB 0.03
- LNTH 0.46
- Stochastic Oscillator
- KTB 61.94
- LNTH 10.57
About KTB Kontoor Brands Inc.
Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.